LIAO Ri-qiang, YANG Xue-ning. Two Immune Checkpoint Inhibitors in PhaseⅠ Clinical Study of Efficacy[J]. Journal of Evidence-Based Medicine, 2015, 15(3): 132-133. DOI: 10.3969/j.issn.1671-5144.2015.03.004
|
Citation:
|
LIAO Ri-qiang, YANG Xue-ning. Two Immune Checkpoint Inhibitors in PhaseⅠ Clinical Study of Efficacy[J]. Journal of Evidence-Based Medicine, 2015, 15(3): 132-133. DOI: 10.3969/j.issn.1671-5144.2015.03.004
|
LIAO Ri-qiang, YANG Xue-ning. Two Immune Checkpoint Inhibitors in PhaseⅠ Clinical Study of Efficacy[J]. Journal of Evidence-Based Medicine, 2015, 15(3): 132-133. DOI: 10.3969/j.issn.1671-5144.2015.03.004
|
Citation:
|
LIAO Ri-qiang, YANG Xue-ning. Two Immune Checkpoint Inhibitors in PhaseⅠ Clinical Study of Efficacy[J]. Journal of Evidence-Based Medicine, 2015, 15(3): 132-133. DOI: 10.3969/j.issn.1671-5144.2015.03.004
|
DownLoad: